←
RadOncUH763 posts
RadOncUH avatar

RadOncUH

@RadOncUH

Department of Radiation Oncology University Hospitals Seidman Cancer Center Case Western Reserve University

◷ Joined May 2021▧ 129 Photos and videos
RadOncUH avatar
RadOncUH@RadOncUH·Oct 26

🏆 Gold Award Winner! Our RadOnc Residency video was recognized as Best Video Content (Over 2min) at the 2026 eHealthcare Awards. 🙏🏼🙏🏼to everyone who helped bring our story to life. ehealthcareawards.com/2026-w… @lauren_henke @angela_jia_ @DrSpratticus @HaleyPerlow @PranshuMohindra

Here at @RadOncUH we train our residents to become the trailblazers for tomorrow’s standard of care. @lauren_henke @angela_jia_ Full video here: youtu.be/hfAxfEtflk0?si=hFze…

1:00
Lauren Henke, MD, MSCI avatar
⟳ RadOncUH retweeted
Lauren Henke, MD, MSCI@lauren_henke·Oct 18

Proud to be on Luke’s cheer squad today as he rang the bell for @Browns #CrucialCatch for cancer screening. Luke’s a ⭐️, bravely sharing his story of young-onset colorectal cancer. Get screened, & if you have symptoms, get tested ASAP. It might save your life. 💙 GO BROWNS! 🧡

Post attachmentPost attachmentPost attachment
0:37
Lauren Henke, MD, MSCI avatar
⟳ RadOncUH retweeted
Lauren Henke, MD, MSCI@lauren_henke·Oct 10

Amazing trip to Prague for @ESTRO_RT ’s workshop on direct-to-unit (née sim-free) RT. Got to watch @APrice_BeamOn lecture as faculty & represent our creative @RadOncUH team & collaborators, see many dear friends, & join in as ad-hoc guest physician faculty on a topic I love!

Post attachmentPost attachmentPost attachmentPost attachment
Soumyajit Roy (Soum) avatar
⟳ RadOncUH retweeted
Soumyajit Roy (Soum)@Soum_Roy_RadOnc·Oct 2

Make that THREE papers this week! 🚨 RAPTOR is out: 3,120 men & 11 RCTs. After RT alone, being BCR-free at 5y marked a functional-cure benchmark (8y DM 6.6%; 10y PCSM 2.5%). W/ ADT, late metastatic risk persisted. doi.org/10.1016/j.euo.2026.0… @AmarUKishan @DrSpratticus @alison_tree

Two papers in a week! 🚨 Now out in @IJROBP: after testosterone recovery following RT+ADT, faster PSA kinetics were associated w/ progression but the relationship with metastatic risk was inconsistent. redjournal.org/article/S0360… Just days after our NADIR validation in ARCHES! 🔬

Soumyajit Roy (Soum) avatar
⟳ RadOncUH retweeted
Soumyajit Roy (Soum)@Soum_Roy_RadOnc·Oct 1

Two papers in a week! 🚨 Now out in @IJROBP: after testosterone recovery following RT+ADT, faster PSA kinetics were associated w/ progression but the relationship with metastatic risk was inconsistent. redjournal.org/article/S0360… Just days after our NADIR validation in ARCHES! 🔬

Thrilled to share our ARCHES external validation of NADIR, now in Cancer! In 558 men with mAPMS on enzalutamide, NADIR showed AUC 0.80 w/ strong calibration for predicting PSA ≤0.2 by 6 months. acsjournals.onlinelibrary.wi… @neerajaiims @DrRanaMcKay @AarmstrongDuke @DrSpratticus

Angela Jia avatar
⟳ RadOncUH retweeted
Angela Jia@angela_jia_·Sep 28

incredible turnout, so much fun meeting everyone, the future is bright!

Full house at our @RadOncUH #ASTRO2026 Meet & Greet! 🎯☢️ So much fun meeting the next generation of #RadOnc and introducing them to our residents and faculty. Thanks to everyone who came out—we may have taken over Flight Club just a little 💙

Post attachment
Lauren Henke, MD, MSCI avatar
⟳ RadOncUH retweeted
Lauren Henke, MD, MSCI@lauren_henke·Sep 28

Expert and thoughtful discussion by the indomitable #JaniceLyons (not to mention fabulous colleague @RadOncUH ). Findings right in line with relevant elements of SKAGEN 1, HypoG-01, and Fast-Forward Nodal sub-study findings. But does one size fit all? Some words of caution for T4 disease, under represented here 🚩, and in those with residual modal disease after NAC. 🚩

Post attachmentPost attachmentPost attachmentPost attachment